In the United States, age-related macular degeneration is a leading cause of irreversible vision loss in people who are 60 ...
A new clinical trial suggests stem cell therapy may restore vision in people with advanced dry age-related macular degeneration, a disease that currently has no cure.
Study participants who administered the treatment twice a day had vision improvements that lasted up to two years.
Researchers used retinal pigment epithelial stem cells derived from adult post-mortem eye tissue in a Phase 1/2a clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results